Healing from within
Conquering lymphatic disorders, restoring the body’s immune system
Latest News
Study shows nanofiber scaffolds could treat lymphedema by rerouting lymphatic system around blockage
Researchers at the School of Medicine have developed a possible treatment for lymphedema, the severe swelling of an arm or leg that can occur when the lymph system is blocked. Using scaffolding composed of specially patterned collagen nanofibers, the researchers...
Fibralign wins BSK biotech startup competition!
Wins $30,000 first place prize among >150 amazing startups in CA event held April 7th at Stanford Medical school. Sponsored by BioSciKin, a Chinese biotech venture focused on precision medicine. See full article at http://califesciences.org/bioscikin-1/. Fibralign...
BioBridge® Collagen Matrix receives 510(k) clearance
Fibralign's first product, the BioBridge® Collagen Matrix has received 510(k) clearance from the FDA on January 07, 2016 for use in soft tissue support/repair (K151083). Click to view. BioBridge is a sterile thread-like surgical mesh designed for use in surgery to...
About Us
Fibralign is an award-winning, commercial-stage Stanford-spinout that produces novel therapeutic biomedical devices that are designed to address major unmet medical needs.
The company has launched its first product, the BioBridge Collagen Matrix, which has now been used in over 750 surgeries by leading surgeons in 19 countries for the treatment of secondary lymphedema, a global chronic disease that currently has no cure.
BioBridge® Collagen Matrix
- BioBridge is a novel thread-like scaffold that has been shown in preclinical and clinical studies to repair damaged lymphatic tissue.
- FDA 510(k) cleared Class II device* for use in soft tissue repair.
- CE mark approved, Class III device for surgical treatment of lymphedema.
- KFDA approval (South Korea).
- Commercially available now in the US, Europe, South Korea and Middle East.
* BioBridge has not been approved by the FDA for treatment of lymphedema.
Nanoweave® Technology
Fibralign is developing a pipeline of compelling novel products which are based on its proprietary Nanoweave® scaffolding platform that can be tailored to address a wide range of high-value applications. Nanoweave technology provides the means to precisely print 3D scaffolding in such a way that mimics human tissue nano structure and directly influence the body’s repair function.
Grants, Awards, Partners and Collaborators
Fibralign has been recognized for its vision and potential to impact lives globally.
We are supported in our mission by world class partners and collaborators.
